• 1
    Bernard CCA, Carnagie PR. Experimental autoimmune encephalomyelitis in mice: immunologic response to mouse spinal cord and myelin basic proteins. J Immunol 1975;114:153740.
  • 2
    Ben-Nun A, Wekerle H, Cohen IR. Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature 1981;292:601.
  • 3
    Lohse AW, Schwerdt A, Herkel J, Spahn T, zum Büschenfelde K-HM. Lack of requirement for CD8+ cells in recovery from and resistance to experimental autoimmune encephalomyelitis. J Autoimmun 1995;8:395404.DOI: 10.1006/jaut.1995.0031
  • 4
    Peng B, Yoshitoshi T, Shichi H. Suppression of experimental autoimmune uveoretinitis by intraorchidic administration of S-antigen. Autoimmunity 1992;14:14953.
  • 5
    Ren J, Shichi H. Induction of immunotolerance by orchidic administration of S-antigen: suppression of uveitis by cell transfer. Regional Immunol 1994;6:17780.
  • 6
    Ren J, Singh AK, Shichi H. Characteristics of immunotolerance induced by intratesticular injection of S-antigen. Ocul Immunol Inflamm 1995;3:12937.
  • 7
    Ditzian-Kadanoff R. Testicular-associated immune deviation and prevention of adjuvant-induced arthritis by three tolerization methods. Scand J Immunol 1999;50:1508.DOI: 10.1046/j.1365-3083.1999.00567.x
  • 8
    Kuruvilla AP, Shah R, Hochwald GM, Liggit HD, Palladino MA, Thorbecke GJ. Protective effect of TGFβ1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci USA 1991;88:291821.
  • 9
    Johns LD, Flanders KC, Ranges GE, Sriram S. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β1. J Immunol 1991;147:17926.
  • 10
    Nusseblatt R, Caspi RR, Mahdi R et al. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol 1990;144:168995.
  • 11
    Streilein JW. Immune regulation and the eye: a dangerous compromise. FASEB J 1987;1:199208.
  • 12
    Hurst EW. The effects of the injection of the normal brain emulsion into rabbits with special reference to the aetiology of the paralytic accidents of antirabic treatment. J Hyg 1932;32:3344.
  • 13
    Rivers TM, Sprunt DH, Berry GB. Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J Exp Med 1933;58:3955.
  • 14
    Rivers TM, Schwentker FF. Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys. J Exp Med 1935;61:689705.
  • 15
    Ren J, Singh A, Gregerson DS, Shichi H. Induction of immunotolerance in rats by intratesticular administration of eicosapeptide of bovine S-antigen. Autoimmunity 1996;25:1931.
  • 16
    Bernard CCA. Experimental autoimmune encephalomyelitis in mice: genetic control susceptibility. J Immunogenet 1976;3:26374.
  • 17
    Berlin BS, McKinney RW. A simple device for making emulsified vaccines. J Lab Clin Med 1958;52:657.
  • 18
    Head JR, Billingham RE. Immune privilege in the testis. II. Evaluation of potential local factors. Transplantation 1985;40:26975.
  • 19
    Maddocks S, Setchell BP. Recent evidence for immune privilege in the testis. J Reprod Immunol 1990;18:918.
  • 20
    Selawry HP, Whittington KP. Prolonged intratesticular islet allograft survival is not dependent on local steroidegenesis. Horm Metab Res 1988;20:5625.
  • 21
    Pöllänen P, von Euler M, Söder O. Testicular immunoregulatory factors. J Reprod Immunol 1990;18:5176.
  • 22
    Kehrl JH, Alvarez-Mon M, Fauci AS. Type β transforming growth factor suppresses the growth and differentiation of human B and T lymphocytes. Clin Res 1985;33:610A.
  • 23
    Kehrl JH, Wakefield LH, Roberts AB et al. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986;163:103750.
  • 24
    Rook MH, Kehrl JH, Wakefield LM et al. Effects of transforming growth factor β on the function of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 1986;136:391620.
  • 25
    Ho SN, Abraham RT, McKean DJ. Inhibition of lymphokine production by transforming growth factor-β. FASEB J 1988;2:A1655.
  • 26
    Lin CS, Siekierka JJ. Transforming growth factor beta (TGF-β) inhibits interleukin-2 (IL-2) production and down-regulates IL-2 receptor in murine T-cells. FASEB J 1988;2:A1656.
  • 27
    Moog C, Fischer P, Dumont. Cyclosporine A, dexamethasone and transforming growth factor-β inhibit distinct steps of T cell activation. FASEB J 1988;2:A1657.
  • 28
    Pöllänen P, von Euler M, Jahnukainen K et al. Localization of transforming growth factor beta in testicular immunosuppression. J Reprod Immunol 1993;24:12337.
  • 29
    Teerds KJ, Dorrington JH. Localisation of transforming growth factor beta 1 and beta 2 during testicular development in the rat. Biol Reprod 1993;448:405.
  • 30
    Tompkins AB, Hutchinson P, deKratser DM, Hedger MP. Characterisation of lymphocytes in the adult rat testis by flow cytometry: Effects of activin and transforming growth factor beta on lymphocyte subsets in virto. Biol Reprod 1998;58:94351.
  • 31
    Khan SA, Schimdt K, Hallin P, Di Pauli R, De Geyter C, Nieschlag E. Human testis cytosol and ovarian fluid contain high amounts of interleukin-1-like factor (s). Mol Cell Endocrinol 1988;58:22130.
  • 32
    Syed V, Söder O, Arver S, Lindh M, Khan S, Ritzen EM. Ontogeny and cellular origin of an interleukin-1-like factor in the reproductive tract of the male rat. Int J Androl 1988;11:43747.
  • 33
    Cudicini C, Lejeune H, Gomez E et al. Human Leydig cells and Sertoli cells are producers of interleukins-1 and -6. J Clin Endocrinol Metab 1997;82:142633.
  • 34
    Stephan JP, Syed V, Jégou B. Regulation of Sertoli cell IL-1 and IL-6 production in vitro. Moll Cell Endocrinol 1997;134:10918.
  • 35
    Sundström J, Veräjänkorva E, Salminen E, Pelliniemi LJ, Pöllänen P. Experimental testicular teratoma promotes formation of humoral immune responses in the host testis. J Reprod Immunol 1999;42:10726.
  • 36
    Veräjänkorva E, Martikainen M, Pöllänen P. Cytokines in the BALB/c mouse testis in various conditions. Asian J Androl 2001;3:919.
  • 37
    Du X, Everett ET, Wang G, Lee WH, Yang Z, Willliams DA. Murine interleukin-11 (IL-11) is expressed at high levels in the hippocampus and expression is developmentally regulated in the testis. J Cell Physiol 1996;168:36272.
  • 38
    Valenti S, Villaaggio B, Cutolo M, Giusti M, Giardano G. Preliminary data suggesting production of interleukin-12 by rat Leydig cells cultured in vitro. Ann N Y Acad Sci 1999;876:25661.
  • 39
    Lee J, Richburg JH, Younkin SC, Boekelheide K. The Fas system is a key regulator of germ cell apoptosis in the testis. Endocrinology 1997;138:20818.
  • 40
    Dejucq N, Dugast I, Ruffault A, van der Meide PH, Jégou B. Interferon-alpha and gamma expression in the rat testis. Endocrinology 1995;11:492531.
  • 41
    De SK, Chen HL, Pace JL, Hunt JS, Terranova PF, Enders GC. Expression of tumour necrosis factor-alpha in mouse spermatogenic cells. Endocrinology 1993;133:38996.
  • 42
    Yotsukura J, Huang H, Singh AK, Shichi H. Regulatory cells generated by testicular tolerization to retinal S-antigen: possible involvement of IL-4, IL-10 and TGF-β in the suppression of experimental autoimmune uveoretinitis. Cell Immunol 1997;182:8998.DOI: 10.1006/cimm.1997.1229
  • 43
    Lando Z, Teitelbaaum D, Arnon R. Induction of experimental allergic encephalomyelitis in genetically resistant strains of mice. Nature 1980;287:5512.
  • 44
    Raine CS, Barnett LB, Brown A, Behar T, McFarlin DE. Neuropathology of experimental allergic encephalomyelitis in inbread strains of mice. Lab Invest 1980;43:1507.
  • 45
    Tuohy VK, Sobel RS, Lees MB. Myelin proteolipid protein-induced experimental allergic encephalomyelitis: variations of disease expression in different strains of mice. J Immunol 1988;140:112630.
  • 46
    Abromson-Leeman S, Alexander J, Bronson R, Carrol J, Southwood S, Dorf ME. Experimental autoimmune encephalomyelitis-resistant mice have highly encephalitogenic myelin basic protein (MBP) -specific T cell cones that recognize a MBP peptide with high affinity for MHC class II. J Immunol 1995;154:38898.
  • 47
    Erälinna JP, Soilu-Hänninen M, Röyttä M, Hukkanen V, Salmi AA, Salonen R. Blood brain barrier breakdown and increased intracellular adhesion molecule (ICAM-1/CD54) expression after Semliki Forest (A7) virus infection facilitates the development of experimental allergic encephalomyelitis. J Neuroimmunol 1996;66:10314.
  • 48
    Soilu-Hänninen M, Röyttä M, Salmi A, Salonen R. Therapy with antibody against leukocyte integrin VLA-4 (CD49d) is effective and safe in virus-facilitated experimental allergic encephalomyelitis. J Neuroimmunol 1997;72:95105.